Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,395 | -3,160 | -110,559 | -99,835 | -74,827 |
| Depreciation Amortization | 1,614 | 191 | 1,499 | 1,187 | 725 |
| Accounts receivable | -13,571 | -5,185 | -8,088 | -11,746 | -24,644 |
| Accounts payable and accrued liabilities | 6,986 | -2,403 | 15 | -1,365 | -1,268 |
| Other Working Capital | -13,514 | -10,092 | 16,790 | 8,388 | -142 |
| Other Operating Activity | 16,760 | 11,133 | 41,554 | 42,127 | 48,091 |
| Operating Cash Flow | $-14,120 | $-9,516 | $-58,789 | $-61,244 | $-52,065 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,963 | 1,278 | 19,527 | 28,126 | 50,554 |
| PPE Investments | -637 | N/A | -1,532 | -1,295 | -502 |
| Investing Cash Flow | $3,326 | $1,278 | $17,995 | $26,831 | $50,052 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 24,350 | 24,350 | N/A |
| Common Stock Issued | 503 | 11 | 29,756 | -197 | 111 |
| Other Financing Activity | 0 | 0 | 1 | 29,755 | 0 |
| Financing Cash Flow | $503 | $11 | $54,107 | $53,908 | $111 |
| Beginning Cash Position | 28,677 | 28,677 | 15,364 | 15,364 | 15,364 |
| End Cash Position | 18,386 | 20,450 | 28,677 | 34,859 | 13,462 |
| Net Cash Flow | $-10,291 | $-8,227 | $13,313 | $19,495 | $-1,902 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,120 | -9,516 | -58,789 | -61,244 | -52,065 |
| Capital Expenditure | -637 | N/A | -1,545 | -1,295 | -502 |
| Free Cash Flow | -14,757 | -9,516 | -60,334 | -62,539 | -52,567 |